About BirgiMefar Group
BirgiMefar Group is a Healthcare company based in Istanbul (Turkey) founded in 1963, and was acquired by ADQ in June 2022. Parenteral solutions are produced in ampoules, syringes, vials, and bottles. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation.
Company details
The BirgiMefar Group is a CMO engaged in the manufacture of parenteral solutions in ampoules, pre-filled syringes (polypropylene or glass), vials (including lyophilized vials) and bottles, as well as sterile solutions in blow-fill-seal (BFS) containers. The company claims to have received certifications from the Turkish Health Authority, UK MHRA , German Health Authority, Romanian Health Authority and Ukrainian Health Authority in sterile product manufacturing. Birgi is a manufacturer of ampoules and vials and Mefar is a manufacturer of parenteral solutions. Their services mainly include sterile filling, manufacturing in lyophilized vials (have freeze-dryers) and BFS containers. They also offer support services such as analytical method and process validation, stability studies, packaging, cold chain storage and management.
Investors in BirgiMefar Group
BirgiMefar Group has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include ADQ, Stage Capital and Ethemba Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
ADQ is recognized as a leading sovereign investor focused on sustainable economic transformation in Abu Dhabi. | adq.ae | Abu Dhabi, United Arab Emirates | ||
Stage Capital is focused on private equity investments. | stagecap.com | London, United Kingdom | ||
Ethemba Capital is focused on private equity in growth markets. | 2006 | ethembacapital.com | Road Town, British Virgin Islands |
Investor details for BirgiMefar Group
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of BirgiMefar Group
3 dated milestones of BirgiMefar Group across 59 years, from founding to its latest funding, stage changes and deals.
- Founded BirgiMefar Group is founded.
- Exit Acquired by Stage Capital.
- Exit Acquired by ADQ.
Web traffic of BirgiMefar Group
The website of BirgiMefar Group (mefar.com) receives about 1.1K visits a month.
- Monthly visits1.1K
▼ 28.1% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about BirgiMefar Group
BirgiMefar Group was founded in 1963.
BirgiMefar Group is headquartered in Istanbul, Turkey.
The BirgiMefar Group is a CMO engaged in the manufacture of parenteral solutions in ampoules, pre-filled syringes (polypropylene or glass), vials (including lyophilized vials) and bottles, as well as sterile solutions in blow-fill-seal (BFS) containers. The company claims to have received certifications from the Turkish Health Authority, UK MHRA , German Health Authority, Romanian Health Authority and Ukrainian Health Authority in sterile product manufacturing. Birgi is a manufacturer of ampoules and vials and Mefar is a manufacturer of parenteral solutions. Their services mainly include sterile filling, manufacturing in lyophilized vials (have freeze-dryers) and BFS containers. They also offer support services such as analytical method and process validation, stability studies, packaging, cold chain storage and management.
BirgiMefar Group has 3 investors. Key investors include ADQ, Stage Capital, and Ethemba Capital.
Yes. BirgiMefar Group was acquired by ADQ in June 2022.